Why Cetero Research is the Choice for Large Pharmaceuticals

We help you make the best decisions about which new compounds have the most potential to become significant additions to your portfolio.
That’s because we focus on early phase studies, including full-service clinical pharmacology, bioanalytical and scientific affairs. And we have for nearly 30 years. We offer a complete package of specialized early phase services, as well as expert project management to put the pieces together in the most efficient manner. In fact, our customers have made us the industry’s leading early phase CRO.
In some cases, the first-in-human single ascending dose study can lead to an immediate “no-go” decision. And the sooner you have made that decision, the sooner you can focus your attention on more promising compounds.
Our First to Proof-of-Concept service combines multiple studies into one protocol. We can work from your protocol, or consult with you to design a protocol that is flexible enough to allow for changes based on early learning, but precise enough to satisfy regulatory requirements. Once we have a fine-tuned protocol in place, we can overlap single ascending dose (SAD), multiple ascending dose (MAD), bridging PK studies, food effect and proof-of-concept. Instead of the usual 28 to 36 weeks to completion, we can deliver the final result in just 14 to 18 weeks.
There is no faster way to get there than our First to Clinic service. As early phase specialists, we have the capacity to recruit both healthy participants and patients quickly in five different locations and the flexibility to reallocate resources so you can cut recruiting time and get an early start on clinical pharmacology tests.
The decision-making becomes more complex as you move up the line to proof-of-concept. That’s where Cetero can make its most valuable contributions: We have a unique combination of broad experience and depth of resources that can help you move faster without dramatically increasing risk.
So you can have the data you need to make critical decisions in about half the time it took before. Don’t lose another minute. Contact Cetero today.

